Anbio Biotechnology: accounts_payable
| Value | {"amount": 1625255, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ce8d3c5d-b494-456b-a187-9e6a7061da00
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-035802Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/accounts-payable/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ce8d3c5d-b494-456b-a187-9e6a7061da00
History
- no predecessors — first report